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Abstract
Background: DNA fingerprinting by IS6110-RFLP has shown a high incidence of Mycobacterium
tuberculosis isolates having no and low copies of the insertion sequence in Kerala, South India.
Amplified Fragment Length Polymorphism (AFLP) would scan the entire genome rather than a few
repetitive elements, we thought that this technique would help us in differentiating the large
reservoir of isolates from an endemic region. Here we evaluate the ability of Amplified Fragment
Length Polymorphism (AFLP) to type clinical isolates.
Methods: Fifty clinical isolates of M. tuberculosis were analysed by conventional radioactive AFLP
and IS6110- RFLP. M. bovis, M. bovis BCG and two non tuberculous mycobacteria were also
analysed to see species specific differences generated by AFLP. Cluster analysis was performed
using the AFLP profile that showed the maximum polymorphism within M. tuberculosis and this was
compared to the number of copies of IS6110 insertions.
Results:  For AFLP, out of ten primer pairs tested, the EO/MC pair generated maximum
polymorphism among the clinical isolates of M. tuberculosis. The similarity between the isolates
ranged between 88 and 99.5%. Majority (nearly 85%) of the 'low copy' IS6110 isolates clustered
together, while the rest clustered irrespective of the copy numbers. AFLP could show rare
differences between isolates of M. tuberculosis, M. bovis and M. bovis BCG. The AFLP profiles for
non-tuberculous mycobacteria were highly different from those of M. tuberculosis.
Conclusion: Polymorphism generated by AFLP within the M. tuberculosis species is limited and
hence AFLP alone seems to have limited use in fingerprinting the isolates in Kerala. The combined
use of AFLP and IS6110-RFLP showed relatively better differentiation of 'high copy' IS6110 isolates,
but failed to differentiate the 'low copy' isolates. However, the technique may be efficient in inter-
species differentiation, and hence potentially useful in identifying and developing species- specific
markers.
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Background
Tuberculosis claims about 500, 000 deaths annually in
India and the disease is endemic in Kerala, a small state in
the southwest [1]. DNA fingerprinting by RFLP-hybridiza-
tion based on the insertion sequence IS6110 [2] showed a
high prevalence of 'no copy' and single copy isolates of
Mycobacterium tuberculosis in Kerala [3]. This, and other
studies point out that IS6110-based methods have limited
use in regions where there is a high incidence of strains
carrying few copies of IS6110 [4,5]. Spoligotyping, the
next widely used fingerprinting method for M. tuberculosis
complex organisms can efficiently differentiate 'low copy'
(5 or fewer copies of IS6110) strains but again is not as
efficient as RFLP for 'high copy' (6 or more copies of
IS6110) strains [6,7]. Fingerprinting techniques such as
Random Amplification of Polymorphic DNA (RAPD) and
Amplified Fragment Length Polymorphism (AFLP) would
scan the entire genome rather than a few repetitive ele-
ments, and since AFLP can be applied to any genome irre-
spective of its complexity [8], we thought that this
technique would help us in differentiating the large reser-
voir of isolates from an endemic region. AFLP has been
used for strain typing within different bacterial genera [9]
and has also been evaluated in inter- and intra-species typ-
ing of mycobacteria [10-13]. In the present study, we ana-
lyzed clinical isolates of M. tuberculosis from Kerala using
AFLP and looked at the ability of the technique to further
differentiate isolates typed by IS6110-RFLP. The ability of
AFLP to provide inter-species differentiation was used to
prove the validity of the methodology adopted by us.
Methods
Clinical isolates and laboratory strains
Fifty clinical isolates of Mycobacterium tuberculosis, isolated
from TB patients and identified based on their growth
characteristics, colony morphology and biochemical tests
[14] were used in this study. The Laboratory strains of
mycobacteria were M. tuberculosis H37Rv, H37Ra, M. bovis
and  M.bovis  BCG. Two atypical mycobacteria obtained
from clinical samples were also included in the study.
Using INNO-LiPA Mycobacteria (LiPA; Innogenetics, Zwi-
jnaarde, Belgium), one was identified as M. chelonae,
while the other could be identified to genus level only.
The isolates used in this investigation were collected by
our laboratory as a part of a study to screen for anti-TB
drug sensitivity and became part of our local repository.
Since this was a retrospective study on the isolates already
available with us, it was not put up for any clearance to an
ethical committee.
Genomic DNA
Genomic DNA was isolated from mycobacteria using
CTAB method as reported earlier [2].
AFLP analysis
AFLP adapters and primers [8] were custom synthesized
by Sigma Genosys (Table 1). AFLP analysis was carried out
as described by Vos et al [8]. Briefly, about 200 ng
genomic DNA from each strain/isolate was digested with
EcoR I and Mse I (New England Biolabs, Beverly, MA).
Each sample of digested DNA was ligated to EcoR I and
Mse I adapters (5 pmol and 50 pmol respectively). The
ligated mixture was diluted to 1:10 ratio in 1X TE buffer
and used as template for PCR. Just before the PCR, EcoR I
primer was labeled with γ-32P (3000 Ci/mmol ATP), using
T4 polynucleotide kinase (NEB). Five µl template DNA,
30 ng Mse I primer, 5 ng labeled EcoR I primer, were used
for each 20 µl PCR reaction. PCR was carried out in an
iCycler (Bio-Rad Labs, Hercules, CA). As described by Vos
et al (8), the first cycle was carried out at 94°C for 30 sec,
65°C for 30 sec and 72°C for 60 sec. The annealing tem-
perature was lowered each cycle by 0.7°C during the next
12 cycles (touch down phase of 13 cycles) and finally 23
cycles were carried out at 94°C for 30 sec, 56°C for 30 sec
and 72°C for 60 sec.
The PCR products were analyzed by urea-PAGE. Gel
images were visualized in a Phosphor imager (Personal
Molecular Imager FX, Bio-Rad, Hercules, CA).
IS6110-RFLP
This was performed according to the standard protocol
[2].
Cluster analysis was performed using similarity coeffi-
cient based on bands that showed differences among iso-
lates. Bionumerics software v 3 (Applied Maths, Belgium)
was used to create UPGMA dendrogram.
Results
AFLP analysis
The initial AFLP analysis of twenty five clinical isolates of
M. tuberculosis using ten primer combinations showed
that, combinations having a single selective primer
yielded 40–50 bands, while any two selective primers,
when combined, yielded only 15–35 bands. A band, if
either absent or present in 10–90% of the isolates tested
Table 1: Sequences of AFLP adapters and primers(Vos et al., 
1995).
AFLP adapter (EcoR I) oligo 1 : 5'-CTC GTA GAC TGC GTA CC-3'
AFLP adapter (EcoR I) oligo 2 : 5'-AAT TGG TAC GCA GTC TAC-3'
AFLP adapter (Mse I) oligo 1 : 5'-GAC GAT GAG TCC TGA G-3'
AFLP adapter (Mse I) oligo 2 : 5'-TAC TCA GGA CTC AT-3'
Primer, EO (non selective)a : 5'-GAC TGC GTA CCA ATT C-3'
Primer, MO (non selective)a : 5'-GAT GAG TCC TGA GTA A-3'
a Selective primers were synthesized with an extra nucleotide-A, T, G 
or C at the 3' end of the non-selective primer sequence and were 
designated as EA, MT etc. accordingly.BMC Infectious Diseases 2007, 7:86 http://www.biomedcentral.com/1471-2334/7/86
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was considered to be polymorphic for the clinical isolates.
Accordingly, there was relatively low polymorphism
within the species (an average 4.27 % of the total number
of bands/primer pair was polymorphic). But for two iso-
lates of non-tuberculous mycobacteria, the AFLP profiles
for all the primer combinations were highly different from
those of M. tuberculosis (Figure 1). It was observed that the
use of a selective primer pair increased the number of pol-
ymorphic bands while reducing the total number of
bands obtained, whereas nonselective primer pairs had
the opposite effect. Therefore, we analysed fifty clinical
isolates of M. tuberculosis along with the laboratory strains
of M. tuberculosis, M. bovis and BCG using four primer
pairs, with each pair having one selective and one non-
selective primer (EO/MT, EO/MG, EO/MA and EO/MC).
Among these primer combinations, EO/MC combination
showed maximum polymorphism within the M. tubercu-
losis species. The AFLP profiles for isolates of M. bovis and
BCG did not vary much from those of M. tuberculosis,
although there were a few bands that may be species-spe-
cific. In addition, there were a few differences between M.
bovis and the BCG vaccine strain. Figure 2 shows the AFLP
profiles for two primer combinations (EO/MC and EO/
MT) that showed strain-specific differences.
Comparison of AFLP with IS6110- RFLP
Since we obtained maximum differences using the EO/
MC primer pair, we used the AFLP profile obtained with
this primer pair to construct a dendrogram (Figure 3) and
compared this with the IS6110 fingerprinting data. Seven-
teen out of fifty isolates tested had IS6110 copy numbers
ranging from 6 to 17. The remaining 33 were 'low copy'
(0–5 copies) isolates, out of which 21 isolates had one,
and three had no copy at all. This was in line with our ear-
lier report on the high incidence of 'low copy isolates' in
Kerala [3]. Cluster analysis showed three major clusters
with the lowest similarity between them being 88%. The
largest cluster (Cluster1) contained M. tuberculosis H37Rv,
H37Ra and most of the clinical isolates. The subcluster 1a
contained H37Rv, H37Ra and 7 clinical isolates, of which
two were 'no copy' and five had 9 or 10 copies. Similarity
within this subcluster ranged from 96–99.3%. The sub-
cluster 1b had 28 (85%) 'low copy' and four high copy
isolates, with similarity ranging from 96.4 to 99.5%. Clus-
ter 2 contained only M bovis and BCG which are known to
be similar. Eight 'high copy' isolates (with copies varying
from 7 to 17) along with two single copy isolates formed
Cluster 3. This cluster showed least intra-cluster similarity
with values ranging from 94.2–98.5%. Overall, clusters 1
and 2 had 92.8% similarity to each other with only 88%
similarity to cluster 3. The other 3 primer pairs showed
fewer polymorphic bands, showed very little differentia-
tion among the different isolates and were not considered
for numerical analysis (data not shown).
Discussion
In the present study we have used conventional radioac-
tive AFLP in order to evaluate its potential to differentiate
the M. tuberculosis isolates of Kerala. This is an endemic
region where we have reported a high incidence of M.
tuberculosis  strains with low numbers of IS6110  which
makes it difficult to be type them [3]. We used this
method instead of multiplex Fluorescent AFLP, as we were
also interested in developing AFLP-derived markers for
the characterization of the Kerala isolates. However, the
data presented in this paper is restricted to AFLP profiles
and their comparison to IS6110 copy number data for a
set of 50 isolates, of which 33 were 'low copy' isolates. Ini-
tially, our results on twenty-five clinical isolates showed
0–3 polymorphic bands per primer pair while using ten
primer combinations. Using EcoR I/Mse I enzyme combi-
nation, approximately 4% of the total number of bands/
primer combination was polymorphic for M. tuberculosis.
There have been earlier reports on AFLP analysis of Myco-
bacterium tuberculosis. A study using multiplex FAFLP
employing EcoR I and Mse  I enzymes and four primer
AFLP profiles generated by primer combinations EO/MT  (panel A) and EG/MC (panel B) Figure 1
AFLP profiles generated by primer combinations EO/MT 
(panel A) and EG/MC (panel B). Lanes1-8: clinical isolates of 
M. tuberculosis, lanes 9&10: non tuberculous mycobacteria. 
The non-tuberculous mycobacteria have a very different pro-
file from each other as well as from M. tuberculosis isolates. 
The primer pair EG/MC (panel B) shows fewer bands and 
more differences between the isolates as compared to EO/
MT primer pair (panel A)
A B
M. tuberculosis NTM M. tuberculosis NTM
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combinations had shown that 28% of the total number of
fragments obtained were polymorphic [11]. In contrast,
another study using radioactive AFLP and a different
enzyme combination (Apa I/Taq I), demonstrated poor
discrimination within the M. tuberculosis complex [10].
The discrepancy between these studies could be due to the
choice of restriction enzymes and the methodology.
FAFLP involves multiplexing which is not feasible with
the radioactive methodology. Therefore, we have used a
combination of the above methodologies using EcoR I/
Mse I enzyme combination and conventional radioactive
AFLP. Even though one may screen other enzyme combi-
nations to increase polymorphism, our results suggest
that radioactive AFLP is not an easy method for strain dif-
ferentiation in endemic regions. However, AFLP could
clearly differentiate M. tuberculosis from isolates of non-
tuberculous mycobacteria. In our study, even though the
close relationship between members of M. tuberculosis
complex is reflected in AFLP analysis, the rare differences
could also be detected. We characterized a few bands that
differentiated  M. tuberculosis and  M. bovis/BCG by
sequencing and identified three fragments belonging to
RD1, RD4 and RD5 (results not shown). It has been
reported that RD1 is absent only in BCG, while RD4-
RD10 are deleted in both M. bovis and BCG [15]. Our
results therefore correlate well with this data.
Comparing AFLP profile with IS6110 typing data showed
that in AFLP analysis isolates clustered irrespective of the
IS6110 copy number. The IS6110 'low copy' isolates were
not well differentiated as nearly 85% of the low copy iso-
lates clustered together (Fig 3, Cluster 1b). Therefore, it
could be speculated that the low copy strains of Kerala are
not very diverse. But all strains with a single copy of IS
may not be identical, as they fell into different clusters
(both 1 and 3) in the AFLP analysis. The high copy isolates
were relatively better separated than the low copy isolates.
Dendrogram based on the AFLP profile for EO/MC primer  pair showing clustering of clinical isolates of M. tuberculosis  and laboratory strains of M. tuberculosis, M. bovis and BCG Figure 3
Dendrogram based on the AFLP profile for EO/MC primer 
pair showing clustering of clinical isolates of M. tuberculosis 
and laboratory strains of M. tuberculosis, M. bovis and BCG. 
IS6110 copy numbers of various isolates/strains are indi-
cated.
IS6110 copy
number
Cluster 2
Cluster 1b
Cluster 3
Cluster 1a
Cluster 1
AFLP profiles showing differences (arrows) between M.  tuberculosis H37Rv (lane1), H37Ra (lane 2), M. bovis (lane 3)  and BCG (lane 4) Figure 2
AFLP profiles showing differences (arrows) between M. 
tuberculosis H37Rv (lane1), H37Ra (lane 2), M. bovis (lane 3) 
and BCG (lane 4). The profiles shown are for EO/MC (panel 
A) and EO/MT (panel B) primer combinations.
A
H37Rv
BCG
H37Ra
M. bovis
B
H37Rv
BCG
H37Ra
M. bovis
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H37Rv
BCG
H37Ra
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Conclusion
We conclude that conventional radioactive AFLP alone
does not seem to be an efficient fingerprinting method for
M. tuberculosis. The combined use of IS6110-RFLP and
AFLP again can differentiate the 'high copy' isolates to
some extent, but does not differentiate the 'low copy' iso-
lates efficiently. However the technique provides inter-
species differentiation within and outside the M. tubercu-
losis complex and therefore is useful in the development
of species-specific markers. The latest addition to the fin-
gerprinting methods for M. tuberculosis, MIRU-VNTR
[16,17], is efficient and is being adopted by several labs
and we are currently analyzing our isolates using MIRU
fingerprinting. But different fingerprinting techniques
cluster the strains differently, and therefore generally
appear to work independently of each other. Therefore, a
unified fingerprinting system that can neatly pigeonhole
all different strains is yet to be developed.
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